Patents by Inventor Bradford A. Jameson

Bradford A. Jameson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5663294
    Abstract: Synthetic peptide analogs of human kininogen are provided which are conformationally restricted by means of intramolecular bonding. The peptides mimic the biological activity of human kininogen by inhibiting the activity of the biologically significant protease, calpain. The peptides are designed by means of an equilibrium conformational model of the kininogen heavy chain.
    Type: Grant
    Filed: February 7, 1995
    Date of Patent: September 2, 1997
    Assignee: Temple University of the Commonwealth System of Higher Education
    Inventors: Robert W. Colman, Harlan N. Bradford, Bradford A. Jameson
  • Patent number: 5645837
    Abstract: Compounds that inhibit CD8 mediated T cell activation and that have a molecular surface that corresponds to the molecular surface of human CD8 at amino acids 53-56 and/or 60-67 and pharmaceutical compositions comprising such compounds are disclosed. Method of inhibiting activation of a human T cell are disclosed. The methods comprise contacting a T cell with a compound that inhibits CD8 mediated T cell activation and that has a molecular surface that corresponds to the molecular surface of human CD8 at amino acids 53-56 and/or 60-67. Methods of treating an individual suspected of suffering from or susceptible to graft versus host disease and/or organ rejection are disclosed. The methods comprise administering an effective amount of a compound that inhibits CD8 mediated T cell activation and that has a molecular surface that corresponds to the molecular surface of human CD8 at amino acids 53-56 and/or 60-67.
    Type: Grant
    Filed: January 17, 1995
    Date of Patent: July 8, 1997
    Assignee: Thomas Jefferson University
    Inventors: Bradford A. Jameson, Swati Choksi, Robert Korngold
  • Patent number: 5589458
    Abstract: Compounds which display a surface similar to the surface presented by one of five distinct lateral domains of CD4 are disclosed. Methods of treating individuals suspected of suffering from or susceptible to conditions characterized by an undesired immune response comprising administering to the individual at least one compound which mimics a portion of the lateral surface of the CD4 glycoprotein are disclosed.
    Type: Grant
    Filed: June 11, 1993
    Date of Patent: December 31, 1996
    Assignee: Thomas Jefferson University
    Inventors: Bradford A. Jameson, James M. McDonnell, Robert Korngold
  • Patent number: 5473054
    Abstract: Short peptides which function as analogs of IGF-1 are provided. These peptides abolish the proliferation of cells at nanogram concentrations. The peptides are non-toxic, and the inhibitor effect is reversible. The use of these peptides, because of their low toxicity and high efficiency, holds promises for treatment of a variety of human conditions, including prevention of restenosis of the coronary arteries after angioplasty, treatment of human neoplasia such as cancer of the prostate, treatment of tumors in pleural and peritoneal cavities and brain metastases, treatment of other abnormalities of cell growth in human beings, treatment of smooth muscle cell hyperplasia in asthma, treatment to promote burn and wound healing, and purging bone marrow from highly proliferating cells.
    Type: Grant
    Filed: March 30, 1994
    Date of Patent: December 5, 1995
    Assignee: Thomas Jefferson University
    Inventors: Bradford A. Jameson, Renato Baserga